Biocon launches Liraglutide injection (Diavorin & Vobexoryn) for diabetes and weight management in the Netherlands with ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

Biocon Ltd on Monday said it has launched its diabetes and chronic, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV.   The drug-device combination will be marketed in ...

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

Bynes has been vocal about her weight-loss journey, which began in June with the trendy GLP-1 agonist drug Ozempic so she ...